Development of a predictive tool for sacral nerve modulation implantation in the treatment of non-obstructive urinary retention and/or slow urinary stream: a study from the Neuro-Urology Committee of the French Association of Urology.

Humans Female Urinary Retention / therapy Retrospective Studies Urology Electric Stimulation Therapy Treatment Outcome Electrodes, Implanted

Non-obstructive urinary retention Predictive factor Sacral neuromodulation Urinary retention

Journal

World journal of urology

ISSN: 1433-8726

Titre abrégé: World J Urol

Pays: Germany

ID NLM: 8307716

Informations de publication

Date de publication:
Nov 2023

Historique:

received: 04 07 2023

accepted: 10 09 2023

medline: 9 11 2023

pubmed: 3 10 2023

entrez: 2 10 2023

Statut: ppublish

Résumé

This study aimed to seek predictive factors and develop a predictive tool for sacral nerve modulation (SNM) implantation in patients with non-obstructive urinary retention and/or slow urinary stream (NOUR/SS). This study was designed as a retrospective study including all patients who have undergone a two-stage SNM for NOUR/SS between 2000 and 2021 in 11 academic hospitals. The primary outcome was defined as the implantation rate. Secondary outcomes included changes in bladder emptying parameters. Univariate and multivariable logistic regression analysis were performed and determined odds ratio for IPG implantation to build a predictive tool. The performance of the multivariable model discrimination was evaluated using the c-statistics and an internal validation was performed using bootstrap resampling. Of the 357 patients included, 210 (58.8%) were finally implanted. After multivariable logistic regression, 4 predictive factors were found, including age (≤ 52 yo; OR = 3.31 The present study identified 4 predictive factors, allowing to develop a predictive tool for SNM implantation in NOUR/SS patients, that may help in guiding therapeutic decision-making. External validation of the tool is warranted.

Identifiants

DOI: 10.1007/s00345-023-04638-y PMID: 37783844

pubmed: 37783844

doi: 10.1007/s00345-023-04638-y

pii: 10.1007/s00345-023-04638-y

doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

Pagination

3075-3082

Informations de copyright

Références

Haylen BT, Maher CF, Barber MD, Camargo S, Dandolu V, Digesu A et al (2016) Erratum to: an International Urogynecological Association (IUGA) / International Continence Society (ICS) joint report on the terminology for female pelvic organ prolapse (POP). Int Urogynecol J 27(4):655–684

doi: 10.1007/s00192-016-3003-y pubmed: 26984443

D’Ancona C, Haylen B, Oelke M, Abranches-Monteiro L, Arnold E, Goldman H et al (2019) The International Continence Society (ICS) report on the terminology for adult male lower urinary tract and pelvic floor symptoms and dysfunction. Neurourol Urodyn 38(2):433–477

doi: 10.1002/nau.23897 pubmed: 30681183

Osman NI, Chapple CR, Abrams P, Dmochowski R, Haab F, Nitti V et al (2014) Detrusor underactivity and the underactive bladder: a new clinical entity? A review of current terminology, definitions, epidemiology, aetiology, and diagnosis. Eur Urol 65(2):389–398

doi: 10.1016/j.eururo.2013.10.015 pubmed: 24184024

Gamé X, Phé V, Castel-Lacanal E, Forin V, de Sèze M, Lam O et al (2020) Intermittent catheterization: clinical practice guidelines from Association Française d’Urologie (AFU), Groupe de Neuro-urologie de Langue Française (GENULF), Société Française de Médecine Physique et de Réadaptation (SOFMER) and Société Interdisciplinaire Francophone d’UroDynamique et de Pelvi-Périnéologie (SIFUD-PP). Prog Urol 30(5):232–251

doi: 10.1016/j.purol.2020.02.009 pubmed: 32220571

Roberson D, Newman DK, Ziemba JB, Wein A, Stambakio H, Hamilton RG et al (2021) Results of the patient report of intermittent catheterization experience (PRICE) study. Neurourol Urodyn 40(8):2008–2019

doi: 10.1002/nau.24786 pubmed: 34516673

Tanagho EA, Schmidt RA (1988) Electrical stimulation in the clinical management of the neurogenic bladder. J Urol 140(6):1331–1339

doi: 10.1016/S0022-5347(17)42038-6 pubmed: 3057221

Arlandis S, Bø K, Cobussen-Boekhorst H, Costantini E, de Heide M, Farag F et al (2022) European Association of Urology Guidelines on the management of female non-neurogenic lower urinary tract symptoms. Part 2: underactive bladder, bladder outlet obstruction, and nocturia. Eur Urol 82(1):60–70

doi: 10.1016/j.eururo.2022.01.044 pubmed: 35181193

Jairam R, Drossaerts J, Marcelissen T, van Koeveringe G, Vrijens D, van Kerrebroeck P (2022) Predictive factors in sacral neuromodulation: a systematic review. Urol Int 106(4):323–343

doi: 10.1159/000513937 pubmed: 34058731

Gross C, Habli M, Lindsell C, South M (2010) Sacral neuromodulation for nonobstructive urinary retention: a meta-analysis. Female Pelvic Med Reconstr Surg 16(4):249–253

doi: 10.1097/SPV.0b013e3181df9b3f pubmed: 22453352

Ho FCS, He C, Yao HH, O’Connell HE, Gani J (2021) Efficacy of sacral neuromodulation and percutaneous tibial nerve stimulation in the treatment of chronic nonobstructive urinary retention: a systematic review. Neurourol Urodyn 40(5):1078–1088

doi: 10.1002/nau.24694 pubmed: 33973670

Chartier-Kastler E, Le Normand L, Ruffion A, Dargent F, Braguet R, Saussine C et al (2021) Sacral neuromodulation with the InterStim™ system for intractable lower urinary tract dysfunctions (SOUNDS): results of clinical effectiveness, quality of life, patient-reported outcomes and safety in a french multicenter observational study. Eur Urol Focus 7(6):1430–1437

doi: 10.1016/j.euf.2020.06.026 pubmed: 32907782

Goldman HB, Lloyd JC, Noblett KL, Carey MP, Castaño Botero JC, Gajewski JB et al (2018) International Continence Society best practice statement for use of sacral neuromodulation. Neurourol Urodyn 37(5):1823–1848

doi: 10.1002/nau.23515 pubmed: 29641846

Harrell FE, Lee KL, Mark DB (1996) Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Statist Med 15(4):361–387

doi: 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4

Gani J, Hennessey D (2017) The underactive bladder: diagnosis and surgical treatment options. Transl Androl Urol 6(S2):S186–S195

doi: 10.21037/tau.2017.04.07 pubmed: 28791238 pmcid: 5522796

Patra PB, Patra S (2013) Sex differences in the physiology and pharmacology of the lower urinary tract. Curr Urol 6(4):179–188

doi: 10.1159/000343536 pubmed: 24917740 pmcid: 3783278

Coolen RL, Groen J, Stillebroer AB, Scheepe JR, Witte LPW, Blok BFM (2022) Two-staged sacral neuromodulation for the treatment of nonobstructive urinary retention: a multicenter study assessing predictors of success. Neuromodulation [Internet]. 2022 Jun 9 [cited 2022 Dec 23];0(0). https://www.neuromodulationjournal.org/article/S1094-7159(22)00653-5/fulltext

Saber-Khalaf M, Abtahi B, Gonzales G, Helal M, Elneil S (2015) Sacral neuromodulation outcomes in male patients with chronic urinary retention. Neuromodul Technol Neural Interface. 18(4):329–334

doi: 10.1111/ner.12268

Al Hashimi I, Saussine C, Tricard T (2022) Sacral neuromodulation in the management of non-obstructive urinary retention: test phase and predictive factors. Prog Urol S1166–7087(22):00474–00482

High RA, Winkelman W, Panza J, Sanderson DJ, Yuen H, Halder GE et al (2021) Sacral neuromodulation for symptomatic chronic urinary retention in females: do age and comorbidities make a difference? Int Urogynecol J 32(10):2703–2715

doi: 10.1007/s00192-020-04485-0 pubmed: 32902761

Yu YD, Jeong SJ (2017) Epidemiology of underactive bladder: common but underresearched. Investig Clin Urol 58(Suppl 2):S68-74

doi: 10.4111/icu.2017.58.S2.S68 pubmed: 29279878 pmcid: 5740032

Panicker JN, Fowler CJ, Kessler TM (2015) Lower urinary tract dysfunction in the neurological patient: clinical assessment and management. Lancet Neurol 14(7):720–732

doi: 10.1016/S1474-4422(15)00070-8 pubmed: 26067125

Timoh KN, Canlorbe G, Verollet D, Peyrat L, Ballester M, Amarenco G et al (2015) Contribution of sacral neuromodulation to manage persistent voiding dysfunction after surgery for deep infiltrating endometriosis with colorectal involvement: preliminary results. Eur J Obstet Gynecol Reprod Biol 1(190):31–35

doi: 10.1016/j.ejogrb.2015.04.011

Agnello M, Vottero M, Bertapelle P (2021) Sacral neuromodulation to treat voiding dysfunction in patients with previous pelvic surgery for deep infiltrating endometriosis: our centre’s experience. Int Urogynecol J 32(6):1499–1504

doi: 10.1007/s00192-020-04478-z pubmed: 32803341

Gamé X, Khan S, Panicker J, Hamid R, Elneil S, Fowler C (2010) 2-Stage sacral neuromodulation for treating chronic urinary retention in women: outcome and response prognostic factors. Neurourol Urodyn 21:1081–1083

De Wachter S, Vaganee D, Kessler TM (2020) Sacral neuromodulation: mechanism of action. Eur Urol Focus 6(5):823–825

doi: 10.1016/j.euf.2019.11.018 pubmed: 32019718